China is already the fastest growing market in the world for pharmaceuticals. Now, after billions of dollars of government and private investment, China is transforming itself into a world leader in biotechnology.

ChinaBio® Today focuses exclusively on the rapidly evolving biotech and life science industry in China. From our offices in Shanghai and San Diego, California, we provide daily news, commentary and analysis on public and private China life science companies and industry events, as well as global issues affecting the China market.

Our parent organization, ChinaBio® LLC, provides consulting services to leading investment organizations and companies involved in the China life science industry, including Roche, Pfizer, Life Technolgoies, and others.  We also provide funding and guidance to promising early stage China biotechs through ChinaBio® Accelerator (www.ChinaBioLLC.com), and organize seminars and conferences in China, such as our annual ChinaBio® Partnering Forum (www.CBPF2010.com) and our ChinaBio® Investor Forums (see Upcoming Events) and ChinaBio® Executive Workshops (www.CBEW2010.com).  

Publisher and Executive Editor: Greg B. Scott
Business Editor: Richard Daverman, PhD

Read more about Our Approach, Our Editors and Our Sponsors below...

In This Category

• Our Approach
• Our Editors
• Our Partners